Apellis Pharmaceuticals (APLS) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Apellis Pharmaceuticals (APLS) over the last 5 years, with Sep 2025 value amounting to $1.67.
- Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) rose 463.04% to $1.67 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.31, marking a year-over-year increase of 115.35%. This contributed to the annual value of -$1.60 for FY2024, which is 64.04% up from last year.
- Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $1.67 in Q3 2025, which was up 606.06% from -$0.33 recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $1.67 in Q3 2025 and a low of -$2.32 during Q2 2021.
- In the last 3 years, Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.54 in 2024 and averaged -$0.50.
- Per our database at Business Quant, Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 195.27% in 2021 and then surged by 463.04% in 2025.
- Over the past 5 years, Apellis Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.53 in 2021, then rose by 1.96% to -$1.50 in 2022, then surged by 52.00% to -$0.72 in 2023, then soared by 59.72% to -$0.29 in 2024, then skyrocketed by 463.04% to $1.67 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $1.67 for Q3 2025, versus -$0.33 for Q2 2025 and -$0.74 for Q1 2025.